.56
[]. Moasser MM, et al. The tyrosine kinase inhibitor ZD39 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 200 Oct ;6(9):4-.
[2]. Pedersen MW, et al. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer. 2005 Oct ;93():95-23.
H302-H35-H39-H335
P26-P264-P20-P2-P20-P302+P352-P304+P340-P330-P362+P364-P405-P50
GHS0